Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly (BATS: QBF)

Latest news for Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly (BATS:QBF)

Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

Blackrock’s Bitcoin Fund Breaks Records With Historic ETF Launch—Will It Surpass The World’s Biggest Gold ETF In January?

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

New ETFs

ETFs

$BTC

Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

Innovator Capital Management rolled out the Uncapped Bitcoin 20 Floor ETF – Quarterly (BATS:QBF), on Feb. 6, with a competitive expense ratio of 0.79%.

New Bitcoin ETF Limits Losses To 20%, Offers Risk-Controlled Exposure

Trane Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) has outperformed the market over the past 20 years by 4.57% on an annualized basis producing an average annual return of 12.98%. Currently, Trane Technologies has a market capitalization of $80.98 billion. 
Buying $100 In TT: If an investor had bought $100 of TT stock 20 years ago, it would be worth $1,145.06 today based on a price of $359.87 for TT at the time of writing.
<h3>Trane Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739285122_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Watching Tempus, Company To Report Q4 And FY24 Financial Results On Feb. 24

Barclays analyst Gena Wang maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Equal-Weight and raises the price target from $435 to $467.

Price Target

Analyst Ratings

VRTX

Barclays Maintains Equal-Weight on Vertex Pharmaceuticals, Raises Price Target to $467

GSAT

Trading Halt: Halt status updated at 9:40:00 AM ET: Quotation Resumption: New Issue Available

Carrier Global Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) shares are trading lower after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43618132/carrier-reports-strong-2024-results-and-announces-2025-outlook" rel="noreferrer noopener">reported mixed fourth-quarter results</a>.
Net sales rose 19% year over year to $5.148 billion, missing the consensus of $5.275 billion. Net sales included 6% organic growth and 13% net contribution from acquisitions and divestitures.
HVAC sales grew 11% organically, led by strong growth in America. EMEA remained flat organically, while Asia Pacific saw slight gains, driven by Japan and South Asia.
Refrigeration sales declined 6% organically, mainly due to lower North America truck and trailer sales, while other segments remained flat.
GAAP operating profit of $774 million was up over 44% from last year, boosted by a Commercial Refrigeration sale. Adjusted operating&nbsp;profit grew 65% to $678 million, driven by Viessmann, organic growth, and productivity gains.
The operating margin expanded by 255 bps to 15%, and the adjusted operating margin expanded by 370 bps to 13.2%.
The company reported adjusted EPS of $0.54 (+50% YoY), <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">beating the consensus of $0.50.</a>
Operating cash flow for fiscal 2024 totaled $563 million, and capital expenditures were $519 million, resulting in a free cash flow of $30 million.
The company exited the quarter with cash and cash equivalents worth $3.969 billion and net debt of $8.309 billion.
&#8220;The quarter also marked the completion of our portfolio transformation, which resulted in total divestiture proceeds of over $10 billion,&#8221; stated Carrier Chairman &amp; CEO David Gitlin.
&#8220;We successfully acquired and integrated Viessmann Climate Solutions in 2024, giving us the most comprehensive and differentiated global portfolio in our industry. We are well-positioned to deliver strong results in 2025, reinforced by our growing global commercial HVAC backlog supported by the acceleration in data centers, commitment to double-digit aftermarket growth, and leading positions across our businesses,&#8221; added Gitlin.
2025 Outlook: Carrier projects accelerated organic growth in 2025 supported by secular tailwinds, <a href="https://www.benzinga.com/calendars/guidance">continued innovation and double-digit aftermarket growth.</a>
The company expects mid-single-digit organic growth with reported sales between $22.5 billion and $23.0 billion versus the consensus of $23.008 billion. This is offset by a $750 million impact from the Commercial Refrigeration divestiture.
CARR sees adjusted EPS of $2.95 – $3.05 versus the consensus of $2.99, reflecting mid- to high-teens growth and an adjusted operating margin of 16.5%—17.0%.
The company forecasts free cash flow of $2.4 billion—$2.6 billion and plans to repurchase approximately $3 billion in shares.
Price Action: CARR shares are trading lower by 3.34% at $64.02 at the last check Tuesday.
Image via Shutterstock.

Earnings

Equities

Guidance

Buybacks

Movers

CARR

Carrier Global Stock Slips After Mixed Q4, CEO Bets Big On 2025 Growth

Craig-Hallum analyst Anthony Stoss maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Hold and lowers the price target from $78 to $50.

Craig-Hallum Maintains Hold on ON Semiconductor, Lowers Price Target to $50

Barclays analyst Julian Mitchell maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Equal-Weight and raises the price target from $285 to $300.

Barclays Maintains Equal-Weight on Rockwell Automation, Raises Price Target to $300

B of A Securities analyst Jason Gerberry maintains Axsome Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) with a Buy and raises the price target from $143 to $167.

AXSM

B of A Securities Maintains Buy on Axsome Therapeutics, Raises Price Target to $167

B of A Securities analyst Michael McGovern maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Buy and raises the price target from $19 to $21.

LYFT

B of A Securities Maintains Buy on Lyft, Raises Price Target to $21

B of A Securities analyst Sara Senatore maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Neutral and raises the price target from $312 to $316.

B of A Securities Maintains Neutral on McDonald's, Raises Price Target to $316

Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) has outperformed the market over the past 10 years by 6.25% on an annualized basis producing an average annual return of 17.41%. Currently, Texas Roadhouse has a market capitalization of $11.54 billion. 
Buying $100 In TXRH: If an investor had bought $100 of TXRH stock 10 years ago, it would be worth $497.60 today based on a price of $173.05 for TXRH at the time of writing.
<h3>Texas Roadhouse's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739284362_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TXRH

$100 Invested In Texas Roadhouse 10 Years Ago Would Be Worth This Much Today

STAI

ScanTech AI Management Confirms Company Has No Convertible Or Variable Rate Indebtedness And No Dilutive Equity Structure On Balance Sheet

B of A Securities analyst Robert Ohmes maintains Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) with a Buy and raises the price target from $165 to $185.

B of A Securities Maintains Buy on Sprouts Farmers Market, Raises Price Target to $185

Barclays analyst Ryan Macwilliams maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Overweight and raises the price target from $325 to $360.

MNDY

Barclays Maintains Overweight on Monday.Com, Raises Price Target to $360

Macro Economic Events

Economics

Federal Reserve

Fed's Hammack Says Federal Government Debt Is On Unsustainable Path Over Longer Term; Rate Hike Is Not In My Base Case, Economy In Good Position; Unclear How Much 2024 Rate Cuts Have Factored Into; We May Be Close To Neutral Rate

Biotech

Government

Regulations

General

BBIO

BEYONTTRA Receives European Commission Marketing Authorization For BEYONTTRA For Treatment Of ATTR-CM

B of A Securities analyst Steve Byrne maintains Bunge Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) with a Buy and lowers the price target from $105 to $87.

B of A Securities Maintains Buy on Bunge Global, Lowers Price Target to $87

Barclays analyst Tim Long maintains Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) with a Equal-Weight and lowers the price target from $14 to $10.

HLIT

Barclays Maintains Equal-Weight on Harmonic, Lowers Price Target to $10

Contracts

ESEA

Euroseas Announces 2-Year Charter Contract Extension For Feeder Containership, M/V EM Hydra; For Minimum Period Of 24 Months And Maximum Period Of 26 Months At Gross Daily Rate Of $19,000

B of A Securities analyst Michael Cherny maintains Progyny (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) with a Buy and raises the price target from $21 to $25.

PGNY

B of A Securities Maintains Buy on Progyny, Raises Price Target to $25

Innovator Capital Management rolled out the Uncapped Bitcoin 20 Floor ETF – Quarterly (BATS:<a class="ticker" href="https://www.benzinga.com/stock/QBF#BATS">QBF</a>), on Feb. 6, with a competitive <a href="https://www.benzinga.com/topic/bitcoin-etf">expense ratio of 0.79%.</a>



The <a href="https://www.benzinga.com/etfs">ETF offers investors exposure</a> to Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price movements while safeguarding investments against significant losses, allowing investors to capture up to 80% of Bitcoin's positive price swings over a quarterly period.



The launch of QBF comes at a time when demand for cryptocurrency exposure is surging, as the crypto world becomes more regulated. However, many investors remain cautious about invest in the volatile asset class. One important differentiating factor of this ETF is it ensures that investors will not lose more than 20% of any price decline, putting hesitant investors at ease.



Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43596456/strategy-acquires-7633-bitcoin-for-742-4-million-boosts-holdings-to-478740-btc">Strategy Acquires 7,633 Bitcoin For $742.4 Million, Boosts Holdings To 478,740 BTC</a>



Unlike traditional Bitcoin ETFs that invest directly in the cryptocurrency, QBF tracks Bitcoin's price movements in a controlled manner. This approach offers investors and financial advisors a structured way to gain crypto exposure without the full brunt of market turbulence.



&#8220;The Fund provides investment exposure to the price return of bitcoin (i.e., "spot" bitcoin prices) (the&nbsp;"Bitcoin Price") by investing in a combination of FLexible EXchange&nbsp;Options ("FLEX Options") that reference one or more exchange-traded&nbsp;products that hold bitcoin directly (each, a&nbsp;"Bitcoin ETP") or the CBOE Bitcoin U.S. ETF Index,&#8221; read an excerpt from its prospectus submitted with the SEC.



&#8220;The Fund seeks to provide shareholders that hold Shares for the entire Outcome Period with a maximum loss experienced by the Bitcoin Price of 20% (the&nbsp;"Floor") over the course of the Outcome Period by holding 80% of the Fund's assets in U.S. Treasuries in order to preserve the Fund's capital in the event the FLEX Options expire worthless,&#8221; the prospectus further read.



The cryptocurrency ETF market continues to expand, with investors increasingly seeking innovative investment solutions. 



As Bitcoin and the broader cryptocurrency market mature, funds like QBF signal a shift toward structured, risk-managed investment products that are suitable for seasoned investors as well as newcomers looking for safer exposure to digital assets.



Read Next:



<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43591727/coinbase-ceo-brian-armstrong-says-bitcoin-adoption-to-reach-billions-by-2030">Coinbase CEO Brian Armstrong Says Bitcoin Adoption To Reach &#8216;Billions&#8217; By 2030</a></li>
</ul>



Photo: Shutterstock

Comments

Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

News

Latest news for Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly (BATS:QBF)

Monday, February 10, 2025

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga